Does a Useful Test Exist to Properly Evaluate the Pathogenicity of Donor-Specific Antibodies? Lessons from a Comprehensive Analysis in a Well-Studied Single-Center Kidney Transplant Cohort.
Fiche publication
Date publication
décembre 2019
Journal
Transplantation
Auteurs
Membres identifiés du Cancéropôle Est :
Dr GACHET Christian
Tous les auteurs :
Gautier Vargas G, Olagne J, Parissiadis A, Joly M, Cognard N, Perrin P, Froelich N, Guntz P, Gachet C, Moulin B, Caillard S
Lien Pubmed
Résumé
Donor-specific antibodies play a major role in antibody-mediated rejection (AMR) and graft dysfunction. However, the clinical relevance of complement-binding anti-HLA antibodies remains unclear.
Référence
Transplantation. 2019 Dec 27;: